EPHEDrine 25 mg/ in 0 recalled over sterility concerns
- Recall date
- December 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals recalls ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals 8521 Kno…
- Recall number
- D-0213-2021
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Product was distributed to hospitals nationwide.
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals 8521 Knoedl Ct., Little Rock, AR, 72205, barcode 70004060409
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals